Assessing the value of autologous and allogeneic cells for regenerative medicine.
about
Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal modelSourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applicationsCustomized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor.Bone Regeneration Based on Tissue Engineering Conceptions - A 21st Century Perspective.Nonhuman primate induced pluripotent stem cells in regenerative medicine.Innovative regenerative medicines in the EU: a better future in evidence?Concise review: cell therapies: the route to widespread adoption.Assessing commercial opportunities for autologous and allogeneic cell-based products.Immunology and cartilage regeneration.Using the cost-effectiveness of allogeneic islet transplantation to inform induced pluripotent stem cell-derived β-cell therapy reimbursement.Challenges and opportunities in the manufacture and expansion of cells for therapy.The translation of cell-based therapies: clinical landscape and manufacturing challenges.Functionalizable silica-based micron-sized iron oxide particles for cellular magnetic resonance imaging.Enhanced survival and neurite network formation of human umbilical cord blood neuronal progenitors in three-dimensional collagen constructs.Allogeneic cell therapy manufacturing: process development technologies and facility design options.Dental Mesenchymal Stem Cell-Based Translational Regenerative Dentistry: From Artificial to Biological Replacement.The Impact of Tissue Storage Conditions on Rat Olfactory Ensheathing Cell Yield and the Future Clinical Implications
P2860
Q27301248-C52710D3-3FF4-411C-ABE5-E5AAC73102F4Q27318423-0ED2081C-85A7-4204-84A0-ACA1199D4FF3Q33588339-0FD69875-C09E-4D0E-8B68-E572F263DD94Q35755087-71FD44AE-F198-455E-9974-F6BA7C572DA8Q35936806-B909162A-D713-46FF-8C69-57C4F76A732BQ36300179-BE757469-004B-4A49-A5DE-E5C44E2FC61FQ36861566-CADAF822-2238-46E1-BB6F-D9DA5AB280FEQ38041271-E1F8D134-D1A7-4C74-843A-D4222C6A5464Q38611262-9BB81EB4-F3A3-4A5C-9FD9-A5E3A7C639D4Q38632041-1A0EE0AF-4254-4A5B-A9D5-3DD402C9D2C8Q38646797-6ECC7A1A-413E-4CEC-B499-EF6765830346Q39063831-0CB74B7C-F866-4833-A3E8-7BA0558D85C1Q39490394-C4244E75-6A44-47DB-A732-FB9838F04AB9Q39504579-7ED88AF9-C150-4149-8EFD-C92585540EC1Q50432799-F7A32D6C-0DAC-4948-9086-3925C73EE350Q53818882-08246A25-98F9-41A7-830C-7425841AD8FBQ57162918-3F3E42B9-FBA9-42BE-A6C4-98AAF9DA6FB1
P2860
Assessing the value of autologous and allogeneic cells for regenerative medicine.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@en
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@nl
type
label
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@en
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@nl
prefLabel
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@en
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@nl
P2860
P356
P1476
Assessing the value of autologous and allogeneic cells for regenerative medicine.
@en
P2093
Chris Mason
Peter Dunnill
P2860
P304
P356
10.2217/RME.09.64
P577
2009-11-01T00:00:00Z